Clinical trial
Von Willebrand Factor and Protein c Ratio-related Thrombogenicity With Systemic Inflammation is Predictive of Graft Dysfunction After Liver Transplantation: Retrospective Cohort Study
NCT04324255 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Von Willebrand Factor and Protein c Ratio-related Thrombogenicity With Systemic Inflammation is Predictive of Graft Dysfunction After Liver Transplantation: Retrospective Cohort Study
- Lead sponsor
- Asan Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2014
- Completion date
- April 30, 2020
- Enrollment
- 1,199 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver transplant; complications